BioAtla, Inc. (BCAB) Reports In-Line Q3 EPS
BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.
BioAtla, Inc. (NASDAQ: BCAB) reported Q3 EPS of ($0.27), in-line with the analyst estimate of ($0.27).
For earnings history and earnings-related data on BioAtla, Inc. (BCAB) click here.